查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575484

肠溶胶囊市场：按功能、聚合物、机制、通路、给药途径、治疗领域 - 2025-2030 年全球预测

Enteric Capsule Market by Functionality, Polymer, Mechanism, Distribution Channel, Route of Administration, Therapeutic Area - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肠溶胶囊市值为6.7453亿美元，预计到2024年将达到7.1332亿美元，复合年增长率为5.81%，到2030年将达到10.0163亿美元。

肠溶胶囊市场包括旨在在肠道而不是胃中释放活性药物成分（API）的标靶药物递送产品。这些胶囊对于保护敏感 API 免受胃酸侵害、增强药效并减少胃肠道副作用至关重要。广泛应用于抗生素、酵素製剂、益生菌製剂等医药产品。最终用途包括药品和食品，主要行业是医院、诊所和网路药局。市场驱动因素包括对标靶药物输送系统的需求不断增加、人口老化需要改进药物输送方法以及胃肠道健康意识的提高。胶囊设计和材料的技术进步提供了多种成长机会，特别是在生物分解性和无毒涂层的开发方面。新的机会在于个人化医疗，肠溶胶囊可以根据特定患者的需求进行定制，为精准药物输送铺平道路。製造商面临的挑战是原材料高成本且监管要求严格，这可能会阻碍市场成长。另一个限制是需要专门的基础设施来製造这些胶囊。为了克服这些挑战，公司可以投资研发，创新具有成本效益的製造工艺，并探索用于胶囊製造的生物分解性材料。最有前景的创新领域包括开发多室胶囊，可容纳不同的原料药，并按顺序释放以实现复杂的治疗方法。进一步探索奈米技术以提高肠溶胶囊在可变 pH 条件下的稳定性也可能提供竞争优势。市场竞争温和，主要参与者主要透过併购和策略联盟来扩大市场份额并丰富产品阵容。肠溶胶囊市场的相关人员必须强调产品差异化和遵守严格的卫生法规，以便在不断变化的消费者需求中保持成长。

主要市场统计
基准年[2023] 67453万美元
预测年份 [2024] 71332万美元
预测年份 [2030] 1,001,630,000 美元
复合年增长率（%） 5.81%

市场动态：快速发展的肠溶胶囊市场的关键市场洞察

供需的动态交互作用正在改变肠溶胶囊市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界人口中胃肠道疾病和病症的盛行率不断增加
    • 在製药业扩大肠溶胶囊的采用，以实现标靶给药并提高疗效
    • 越来越多的消费者喜欢口服药物而不是其他给药方式
  • 市场限制因素
    • 高品质明胶和其他原料的供应有限，破坏了供应链的一致性。
  • 市场机会
    • 利用肠溶胶囊提高针对肠道健康和保健的食品应用中的生物有效性度
    • 胶囊製造流程的技术进步提高了产品品质和性能
    • 扩大肠溶胶囊在动物用药品的使用，以优化兽医胃肠道治疗药物的输送
  • 市场挑战
    • 新配方复杂而漫长的核准流程减缓了新产品的上市速度

波特五力：驾驭肠溶胶囊市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解肠溶胶囊市场的外部影响

外部宏观环境因素对肠溶胶囊市场表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解肠溶胶囊市场竞争格局

肠溶胶囊市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵肠溶胶囊市场供应商的绩效评估

FPNV定位矩阵是评估肠溶胶囊市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了肠溶胶囊市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，肠溶胶囊市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界人口中胃肠道疾病和病症的盛行率不断增加
      • 肠溶胶囊越来越多地被製药业采用，用于标靶给药和提高疗效
      • 与其他给药方式相比，越来越多的消费者更喜欢口服给药
    • 抑制因素
      • 优质明胶和其他原料的供应有限，影响了供应链的一致性
    • 机会
      • 利用肠溶胶囊提高针对肠道健康和保健的营养保健品食品中的生物有效性度
      • 胶囊製造流程的技术进步可提高产品品质和性能
      • 扩大肠溶胶囊在兽药中的使用，以优化动物胃肠道治疗的给药
    • 任务
      • 新配方复杂而漫长的核准流程延迟了新产品的上市时间
  • 市场区隔分析
    • 聚合物类型：合成聚合物因其优异的 pH 依赖性溶解度而被广泛使用。
    • 用途：优先选用肠溶胶囊，以增强药效。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章肠溶胶囊市场：功能性别

  • 延迟释放胶囊
  • 速效胶囊
  • 缓释性胶囊

第七章肠溶胶囊市场：依聚合物分类

  • 动物起源
    • 明胶
    • 虫胶
  • 植物来源
    • 邻苯二甲酸醋酸纤维素 (CAP)
    • 羟丙基甲基纤维素（HPMC）
  • 合成来源
    • 聚(甲基丙烯酸-甲基丙烯酸甲酯)
    • 聚醋酸乙烯酯邻苯二甲酸酯 (PVAP)

第八章肠溶胶囊市场：按机制

  • 延迟释放胶囊
  • 缓释性胶囊
  • 速效胶囊

第九章肠溶胶囊市场：依通路划分

  • 医院药房
  • 网路商店
  • 零售药房

第10章肠溶胶囊市场：依途径

  • 口服
  • 直肠

第十一章肠溶胶囊市场：依治疗领域

  • 心臟病学
  • 糖尿病
  • 胃肠病学
  • 感染疾病
  • 神经病学
  • 肿瘤学

第十二章美洲肠溶胶囊市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太肠溶胶囊市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章欧洲、中东和非洲肠溶胶囊市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 赢创推出功能性口服胶囊「EUDRACAP」用于临床前测试
  • 战略分析和建议

公司名单

  • 1. ACG Worldwide
  • 2. Aenova Group
  • 3. Associated Biotech Group
  • 4. Biocaps Enterprises
  • 5. Bright Pharma Caps Inc.
  • 6. Captek Softgel International Inc.
  • 7. Chemcaps Limited
  • 8. Coating Place Inc.
  • 9. Farmacapsulas SA
  • 10. FUJI Capsule Co., Ltd.
  • 11. GELITA AG
  • 12. GMP Laboratories of America Inc.
  • 13. Hunan ER-Kang Pharmaceutical Co., Ltd.
  • 14. Lonza Group AG
  • 15. Mitsubishi Chemical Holdings Corporation
  • 16. Natural Capsules Limited
  • 17. Nectar Lifesciences Ltd.
  • 18. NextPharma Technologies
  • 19. Qualicaps by Roquette
  • 20. Roxlor LLC
  • 21. Thermo Fisher Scientific Inc.
Product Code: MRR-3204321AF70B

The Enteric Capsule Market was valued at USD 674.53 million in 2023, expected to reach USD 713.32 million in 2024, and is projected to grow at a CAGR of 5.81%, to USD 1,001.63 million by 2030.

The enteric capsule market encompasses products designed for targeted drug delivery, ensuring that active pharmaceutical ingredients (APIs) are released in the intestine rather than the stomach. These capsules are crucial for protecting sensitive APIs from stomach acid, enhancing drug efficacy, and reducing gastrointestinal side effects. They are widely applied in pharmaceuticals for medications like antibiotics, enzymes, and probiotic formulations. The end-use scope extends to pharmaceuticals and dietary supplements, with key sectors being hospitals, clinics, and online pharmacies. The market is driven by the escalating demand for targeted drug delivery systems, an aging population necessitating improved drug administration methods, and increased awareness of gastrointestinal health. Technological advancements in capsule design and materials present multiple growth opportunities, particularly in developing biodegradable and non-toxic coatings. An emerging opportunity lies in personalized medicine, where enteric capsules can be tailored for specific patient needs, thus opening avenues for precision drug delivery. A challenge that manufacturers face is the high cost of raw materials and stringent regulatory requirements, which can hinder market growth. Additionally, the need for specialized infrastructure to manufacture these capsules also poses a limitation. To overcome these challenges, businesses can invest in research and development to innovate cost-effective manufacturing processes and explore biodegradable materials for capsule production. The most promising areas of innovation include the development of multi-compartment capsules, which can house different APIs released sequentially for complex therapeutic regimens. Further exploration into nanotechnology for enhanced stability of enteric capsules in variable pH conditions could also offer a competitive edge. The market is moderately competitive, with key players focusing on mergers, acquisitions, and strategic partnerships to expand market presence and enhance product offerings. Stakeholders in the enteric capsule market must emphasize product differentiation and compliance with stringent health regulations to sustain growth amid evolving consumer demands.

KEY MARKET STATISTICS
Base Year [2023] USD 674.53 million
Estimated Year [2024] USD 713.32 million
Forecast Year [2030] USD 1,001.63 million
CAGR (%) 5.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enteric Capsule Market

The Enteric Capsule Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of gastrointestinal diseases and disorders among global population
    • Growing adoption of enteric capsules in pharmaceutical industry for targeted drug delivery and improved efficacy
    • Rising consumer preference for oral drug administration over other delivery methods
  • Market Restraints
    • Limited availability of high-quality gelatin and other raw materials disrupt supply chain consistency
  • Market Opportunities
    • Leveraging enteric capsules for improved bioavailability in nutraceutical applications targeting gut health and wellness
    • Technological advancements in capsule manufacturing processes to enhance product quality and performance
    • Expanding the use of enteric-coated capsules in veterinary medicine to optimize the delivery of gastrointestinal treatments for animals
  • Market Challenges
    • Intricate and time-consuming approval processes for new formulations delay time-to-market for new products

Porter's Five Forces: A Strategic Tool for Navigating the Enteric Capsule Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enteric Capsule Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enteric Capsule Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enteric Capsule Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enteric Capsule Market

A detailed market share analysis in the Enteric Capsule Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enteric Capsule Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enteric Capsule Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enteric Capsule Market

A strategic analysis of the Enteric Capsule Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enteric Capsule Market, highlighting leading vendors and their innovative profiles. These include ACG Worldwide, Aenova Group, Associated Biotech Group, Biocaps Enterprises, Bright Pharma Caps Inc., Captek Softgel International Inc., Chemcaps Limited, Coating Place Inc., Farmacapsulas S.A, FUJI Capsule Co., Ltd., GELITA AG, GMP Laboratories of America Inc., Hunan ER-Kang Pharmaceutical Co., Ltd., Lonza Group AG, Mitsubishi Chemical Holdings Corporation, Natural Capsules Limited, Nectar Lifesciences Ltd., NextPharma Technologies, Qualicaps by Roquette, Roxlor LLC, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Enteric Capsule Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Functionality, market is studied across Delayed-Release Capsules, Immediate-Release Capsules, and Sustained-Release Capsules.
  • Based on Polymer, market is studied across Animal Origin, Plant-based, and Synthetic Origin. The Animal Origin is further studied across Gelatin and Shellac. The Plant-based is further studied across Cellulose Acetate Phthalate (CAP) and Hydroxypropyl Methylcellulose (HPMC). The Synthetic Origin is further studied across Poly(methacrylic acid-co-methyl methacrylate) and Polyvinyl Acetate Phthalate (PVAP).
  • Based on Mechanism, market is studied across Delayed-Release Capsules, Extended-Release Capsules, and Immediate-Release Capsules.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Stores, and Retail Pharmacies.
  • Based on Route of Administration, market is studied across Oral and Rectal.
  • Based on Therapeutic Area, market is studied across Cardiology, Diabetes, Gastroenterology, Infectious Diseases, Neurology, and Oncology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of gastrointestinal diseases and disorders among global population
      • 5.1.1.2. Growing adoption of enteric capsules in pharmaceutical industry for targeted drug delivery and improved efficacy
      • 5.1.1.3. Rising consumer preference for oral drug administration over other delivery methods
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of high-quality gelatin and other raw materials disrupt supply chain consistency
    • 5.1.3. Opportunities
      • 5.1.3.1. Leveraging enteric capsules for improved bioavailability in nutraceutical applications targeting gut health and wellness
      • 5.1.3.2. Technological advancements in capsule manufacturing processes to enhance product quality and performance
      • 5.1.3.3. Expanding the use of enteric-coated capsules in veterinary medicine to optimize the delivery of gastrointestinal treatments for animals
    • 5.1.4. Challenges
      • 5.1.4.1. Intricate and time-consuming approval processes for new formulations delay time-to-market for new products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Polymer Type: Wide use of synthetic polymers owing to their excellent pH-dependent solubility
    • 5.2.2. Applications: Preference for enteric capsules due to their enhancing drug efficacy
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Enteric Capsule Market, by Functionality

  • 6.1. Introduction
  • 6.2. Delayed-Release Capsules
  • 6.3. Immediate-Release Capsules
  • 6.4. Sustained-Release Capsules

7. Enteric Capsule Market, by Polymer

  • 7.1. Introduction
  • 7.2. Animal Origin
    • 7.2.1. Gelatin
    • 7.2.2. Shellac
  • 7.3. Plant-based
    • 7.3.1. Cellulose Acetate Phthalate (CAP)
    • 7.3.2. Hydroxypropyl Methylcellulose (HPMC)
  • 7.4. Synthetic Origin
    • 7.4.1. Poly(methacrylic acid-co-methyl methacrylate)
    • 7.4.2. Polyvinyl Acetate Phthalate (PVAP)

8. Enteric Capsule Market, by Mechanism

  • 8.1. Introduction
  • 8.2. Delayed-Release Capsules
  • 8.3. Extended-Release Capsules
  • 8.4. Immediate-Release Capsules

9. Enteric Capsule Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Stores
  • 9.4. Retail Pharmacies

10. Enteric Capsule Market, by Route of Administration

  • 10.1. Introduction
  • 10.2. Oral
  • 10.3. Rectal

11. Enteric Capsule Market, by Therapeutic Area

  • 11.1. Introduction
  • 11.2. Cardiology
  • 11.3. Diabetes
  • 11.4. Gastroenterology
  • 11.5. Infectious Diseases
  • 11.6. Neurology
  • 11.7. Oncology

12. Americas Enteric Capsule Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Enteric Capsule Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Enteric Capsule Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Evonik launches EUDRACAP preclinic functional oral capsule for preclinical trials
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ACG Worldwide
  • 2. Aenova Group
  • 3. Associated Biotech Group
  • 4. Biocaps Enterprises
  • 5. Bright Pharma Caps Inc.
  • 6. Captek Softgel International Inc.
  • 7. Chemcaps Limited
  • 8. Coating Place Inc.
  • 9. Farmacapsulas S.A
  • 10. FUJI Capsule Co., Ltd.
  • 11. GELITA AG
  • 12. GMP Laboratories of America Inc.
  • 13. Hunan ER-Kang Pharmaceutical Co., Ltd.
  • 14. Lonza Group AG
  • 15. Mitsubishi Chemical Holdings Corporation
  • 16. Natural Capsules Limited
  • 17. Nectar Lifesciences Ltd.
  • 18. NextPharma Technologies
  • 19. Qualicaps by Roquette
  • 20. Roxlor LLC
  • 21. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ENTERIC CAPSULE MARKET RESEARCH PROCESS
  • FIGURE 2. ENTERIC CAPSULE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENTERIC CAPSULE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. ENTERIC CAPSULE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. ENTERIC CAPSULE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENTERIC CAPSULE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENTERIC CAPSULE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENTERIC CAPSULE MARKET DYNAMICS
  • TABLE 7. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DELAYED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY IMMEDIATE-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SUSTAINED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SHELLAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY CELLULOSE ACETATE PHTHALATE (CAP), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLY(METHACRYLIC ACID-CO-METHYL METHACRYLATE), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYVINYL ACETATE PHTHALATE (PVAP), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DELAYED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY EXTENDED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY IMMEDIATE-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY RECTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 290. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 298. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 299. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 307. NORWAY ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 308. NORWAY ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 316. POLAND ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 317. POLAND ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 325. QATAR ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 326. QATAR ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 334. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 335. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 336. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 337. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 343. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 344. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 345. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 346. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 347. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 348. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 350. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 352. SOUTH AFRICA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 353. SOUTH AFRICA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 354. SOUTH AFRICA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 355. S